Combination of Mesenchymal Stem Cells-delivered Oncolytic Virus and Prodrug Activation Increases Efficacy and Safety in Cancer Therapy
碩士 === 國立陽明大學 === 臨床醫學研究所 === 102 === Oncolytic viruses, such as conditionally replicative adenoviruses (CRAds), have been successfully approved in clinical trials for cancer therapy. However the anti-tumor efficacy was still not ideal. Gene-directed enzyme-prodrug therapy (GDEPT), that is prodrug a...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/56722525246889477551 |